Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Chloramphenicol 1% w/w eye ointment |
| Active Ingredient: | Chloramphenicol 10mg/g |
| Dosage Form: | Eye ointment |
| New Zealand Sponsor: | Devatis Limited |
| Manufacturer: | Deva Holding AS, Tekirdag, Turkey |
| Product: | Fotivda |
| Active Ingredient: | Tivozanib hydrochloride monohydrate 1mg equivalent to tivozanib 890mcg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Emerge Health New Zealand Limited |
| Manufacturer: | Catalent CTS Inc, Missouri, United States of America |
| Product: | Fotivda |
| Active Ingredient: | Tivozanib hydrochloride monohydrate 1.5mg equivalent to tivozanib 1340mcg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Emerge Health New Zealand Limited |
| Manufacturer: | Catalent CTS Inc, Missouri, United States of America |
| Product: | Mebeverine |
| Active Ingredient: | Mebeverine hydrochloride 135mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Generic Partners (NZ) Limited |
| Manufacturer: | RA Chem Pharma Limited, Hyderabad, India |
Dated this 19th day of July 2019.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).